The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration

---

Silva R., Axer-Siegel R., Eldem B., Guymer R., Kirchhof B., Papp A., ...More

OPHTHALMOLOGY, vol.120, no.1, pp.130-139, 2013 (Journal Indexed in SCI)

• Publication Type: Article / Article
• Volume: 120 Issue: 1
• Publication Date: 2013
• Doi Number: 10.1016/j.ophtha.2012.07.026
• Title of Journal : OPHTHALMOLOGY
• Page Numbers: pp.130-139

Abstract

Objective: To evaluate long-term safety of intravitreal ranibizumab 0.5-mg injections in neovascular age-related macular degeneration (nAMD).